Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,otherCurrentAssets,shortLongTermDebt,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,priceHint,shortName,exchange,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,exchangeDataDelayedBy,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,marketState,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry
t0,JNJ.DE,-20964000000.0,2633400064,3178000000,,7429000000,,6197000000,5263000000,15285000000,6844000000,6844000000,,-63000000,,,,1232000000,22321000000,15477000000,7036000000,585000000,,6197000000,6197000000,51110000000.0,106723000000.0,65834000000.0,1877000000.0,172557000000.0,3120000000.0,116508000000.0,35528000000.0,35688000000.0,-53794000000.0,13407000000.0,12671000000.0,40932000000.0,8321000000.0,-15328000000.0,18367000000.0,52533000000.0,1452000000.0,11948000000.0,14938000000.0,30263000000.0,9952000000.0,8503000000.0,,,-761000000,-2336000000,-185000000,-1452000000,-5125000000,1620000000,236000000,-1314000000,-1438000000,-78000000,4074000000,1894000000,650000000,-2659000000,-695000000,-1604000000,188000000,-1002000000,-677000000,11601000000.0,en-US,US,EQUITY,False,Delayed Quote,147.04,1630574973,1.3399963,146.02,147.42,146.02,944,7.5111237,0.05383204,388426727424,5.8801885,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,JOHNSON & JOHNSON,GER,25.006,147.13829,-0.09829712,-0.0006680594,139.52887,0,finmb_139677,XETRA,Johnson & Johnson,USD,5022,5879,30.91999,0.26627618,116.12 - 154.0,-6.9600067,-0.04519485,116.12,154.0,1634646600,1634646600,1634646600,4.04,31.23858,0.02772821,4.707,REGULAR,0.9196955,146.02 - 147.42,145.7,146.72,146.96,0,0,de_market,0.71,,,154.0,116.12,147.14,139.53,5.02k,5.88k,2.63B,,2.63B,0.08%,69.02%,,,,,,3.48,2.46%,4.04,2.77%,2.62,71.38%,,"May 25, 2021",,,"Jan 03, 2021","Apr 04, 2021",17.95%,24.85%,7.98%,23.78%,84.21B,31.99,7.90%,54.26B,28.3B,15.11B,4.71,6.90%,24.62B,9.35,33.61B,51.06,1.28,25.01,24.25B,22.33B,Value,08933,Healthcare,134500,9,10,"Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.",New Brunswick,732 524 0400,NJ,4,1609372800,1625097600,8,United States,http://www.jnj.com,86400,8,One Johnson & Johnson Plaza,Drug Manufacturersâ€”General
t-1,JNJ.DE,-26517000000.0,2633400064,4032000000,,1647000000,,1738000000,6714000000,14692000000,3946000000,3946000000,,-87000000,,,,-91000000,22475000000,18529000000,7783000000,-2299000000,,1738000000,1738000000,53402000000.0,111616000000.0,63278000000.0,1392000000.0,174894000000.0,3120000000.0,113890000000.0,35388000000.0,36393000000.0,-53732000000.0,11903000000.0,13985000000.0,42493000000.0,8534000000.0,-15242000000.0,19766000000.0,51237000000.0,2193000000.0,11200000000.0,13576000000.0,32635000000.0,9344000000.0,9505000000.0,898000000.0,1799000000.0,706000000,5260000000,-7903000000,-2799000000,-5644000000,-1558000000,192000000,-4980000000,-321000000,224000000,8343000000,1940000000,-1117000000,-2658000000,519000000,1214000000,-58000000,-770000000,-1323000000,8744000000.0,en-US,US,EQUITY,False,Delayed Quote,147.04,1630574973,1.3399963,146.02,147.42,146.02,944,7.5111237,0.05383204,388426727424,5.8801885,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,JOHNSON & JOHNSON,GER,25.006,147.13829,-0.09829712,-0.0006680594,139.52887,0,finmb_139677,XETRA,Johnson & Johnson,USD,5022,5879,30.91999,0.26627618,116.12 - 154.0,-6.9600067,-0.04519485,116.12,154.0,1634646600,1634646600,1634646600,4.04,31.23858,0.02772821,4.707,REGULAR,0.9196955,146.02 - 147.42,145.7,146.72,146.96,0,0,de_market,0.71,,,154.0,116.12,147.14,139.53,5.02k,5.88k,2.63B,,2.63B,0.08%,69.02%,,,,,,3.48,2.46%,4.04,2.77%,2.62,71.38%,,"May 25, 2021",,,"Jan 03, 2021","Apr 04, 2021",17.95%,24.85%,7.98%,23.78%,84.21B,31.99,7.90%,54.26B,28.3B,15.11B,4.71,6.90%,24.62B,9.35,33.61B,51.06,1.28,25.01,24.25B,22.33B,Value,08933,Healthcare,134500,9,10,"Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.",New Brunswick,732 524 0400,NJ,4,1609372800,1625097600,8,United States,http://www.jnj.com,86400,8,One Johnson & Johnson Plaza,Drug Manufacturersâ€”General
t-2,JNJ.DE,-16840000000.0,2633400064,2840000000,,4401000000,,3554000000,5336000000,14142000000,5966000000,5966000000,,-44000000,,,,847000000,21082000000,15116000000,6940000000,-1565000000,,3554000000,3554000000,47006000000.0,106220000000.0,64473000000.0,1666000000.0,170693000000.0,3120000000.0,114831000000.0,34693000000.0,34307000000.0,-53478000000.0,12807000000.0,18965000000.0,38847000000.0,7816000000.0,-14938000000.0,17855000000.0,57578000000.0,1140000000.0,11816000000.0,14579000000.0,32680000000.0,9599000000.0,7044000000.0,91000000.0,,-3524000000,2200000000,-4819000000,7204000000,4196000000,475000000,214000000,7791000000,-483000000,31000000,8383000000,1818000000,-571000000,-2659000000,-147000000,80000000,-80000000,403000000,-737000000,18731000000.0,en-US,US,EQUITY,False,Delayed Quote,147.04,1630574973,1.3399963,146.02,147.42,146.02,944,7.5111237,0.05383204,388426727424,5.8801885,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,JOHNSON & JOHNSON,GER,25.006,147.13829,-0.09829712,-0.0006680594,139.52887,0,finmb_139677,XETRA,Johnson & Johnson,USD,5022,5879,30.91999,0.26627618,116.12 - 154.0,-6.9600067,-0.04519485,116.12,154.0,1634646600,1634646600,1634646600,4.04,31.23858,0.02772821,4.707,REGULAR,0.9196955,146.02 - 147.42,145.7,146.72,146.96,0,0,de_market,0.71,,,154.0,116.12,147.14,139.53,5.02k,5.88k,2.63B,,2.63B,0.08%,69.02%,,,,,,3.48,2.46%,4.04,2.77%,2.62,71.38%,,"May 25, 2021",,,"Jan 03, 2021","Apr 04, 2021",17.95%,24.85%,7.98%,23.78%,84.21B,31.99,7.90%,54.26B,28.3B,15.11B,4.71,6.90%,24.62B,9.35,33.61B,51.06,1.28,25.01,24.25B,22.33B,Value,08933,Healthcare,134500,9,10,"Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.",New Brunswick,732 524 0400,NJ,4,1609372800,1625097600,8,United States,http://www.jnj.com,86400,8,One Johnson & Johnson Plaza,Drug Manufacturersâ€”General
t-3,JNJ.DE,-18325000000.0,2633400064,2707000000,,3940000000,,3626000000,4904000000,11779000000,4168000000,4168000000,,-45000000,,,,314000000,18336000000,14168000000,6557000000,-228000000,,3626000000,3626000000,47413000000.0,95402000000.0,62978000000.0,1632000000.0,158380000000.0,3120000000.0,113898000000.0,33568000000.0,33890000000.0,-54040000000.0,12099000000.0,11174000000.0,36772000000.0,7805000000.0,-15533000000.0,17598000000.0,45892000000.0,1488000000.0,7961000000.0,14645000000.0,25062000000.0,9424000000.0,6765000000.0,100000000.0,,-5614000000,204000000,-7522000000,2709000000,-357000000,-1819000000,376000000,-4356000000,-706000000,71000000,3452000000,1726000000,-1306000000,-2659000000,-478000000,292000000,-77000000,-99000000,-662000000,9120000000.0,en-US,US,EQUITY,False,Delayed Quote,147.04,1630574973,1.3399963,146.02,147.42,146.02,944,7.5111237,0.05383204,388426727424,5.8801885,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,JOHNSON & JOHNSON,GER,25.006,147.13829,-0.09829712,-0.0006680594,139.52887,0,finmb_139677,XETRA,Johnson & Johnson,USD,5022,5879,30.91999,0.26627618,116.12 - 154.0,-6.9600067,-0.04519485,116.12,154.0,1634646600,1634646600,1634646600,4.04,31.23858,0.02772821,4.707,REGULAR,0.9196955,146.02 - 147.42,145.7,146.72,146.96,0,0,de_market,0.71,,,154.0,116.12,147.14,139.53,5.02k,5.88k,2.63B,,2.63B,0.08%,69.02%,,,,,,3.48,2.46%,4.04,2.77%,2.62,71.38%,,"May 25, 2021",,,"Jan 03, 2021","Apr 04, 2021",17.95%,24.85%,7.98%,23.78%,84.21B,31.99,7.90%,54.26B,28.3B,15.11B,4.71,6.90%,24.62B,9.35,33.61B,51.06,1.28,25.01,24.25B,22.33B,Value,08933,Healthcare,134500,9,10,"Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.",New Brunswick,732 524 0400,NJ,4,1609372800,1625097600,8,United States,http://www.jnj.com,86400,8,One Johnson & Johnson Plaza,Drug Manufacturersâ€”General
